Developing life-saving oncology therapeutics, cardiovascular treatments, and vaccines globally, Anglo-Swedish pharma giant AstraZeneca (AZN) is one of the FTSE 100's largest healthcare heavyweights.
If you're analysing global pharmaceutical leaders and want to understand how to buy AstraZeneca shares, you just need a few minutes and a reliable trading app. Here's everything you need to know about how to buy AstraZeneca stock.
How to buy shares in AstraZeneca
- Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, sign up on your chosen platform.
- Fund your account. Add money to your account via bank transfer or debit card.
- Search the platform by ticker symbol. AZN in this case.
- Choose an order type. Place a market order (or limit order, if you want to try to hold out for a specific price) with your preferred number of shares or investment amount.
- Submit the order. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our top picks for where to buy AstraZeneca shares
Best for 0% commission stocks
Capital at risk. Fees apply. T&Cs apply
- Commission-free trades
- Fractional shares
- Free to open an account
Best for active investing
Capital at risk. T&Cs apply
- Commission-free trades
- 11,000+ stocks & ETFs
- Advanced trading tools
Best for trading tools
Capital at risk. T&Cs apply
- Commission-free trades
- 16,000+ stocks and ETFs
- Fractional shares
Latest updates for AstraZeneca
May 22, 2026: AstraZeneca received a positive CHMP opinion recommending EU approval of camizestrant plus a CDK4/6 inhibitor for advanced ER-positive breast cancer, based on the SERENA-6 Phase III trial.
Share dealing platform comparison
Looking for other options? Check out these similar products.
How we picked theseFinder Score for trading platforms
To make comparing even easier we came up with the Finder Score. Costs, features, ease and range of investments across 30+ platforms are all weighted and scaled to produce a score out of 10. The higher the score the better the platform – simple.
Read the full methodologyAll investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Boost your investment IQ!
Subscribe now for market insights, expert advice and a chance to win £100! (T&Cs)
Is it a good time to buy AstraZeneca stock?
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
How does that compare?
- Over 5,500+ stocks from 20 exchanges
- Free to open an account
- Commission-free trading
Frequently asked questions
-
Dividend yield: 2.33% of stock value
Forward annual dividend yield: 1.72% of stock value
Dividend payout ratio: 23.62% of net profits
AstraZeneca has recently paid out dividends equivalent to 2.33% of its share value annually.
AstraZeneca has paid out, on average, around 23.62% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.72% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 1.72% return on their shares, in the form of dividend payments. In AstraZeneca's case, that would currently equate to about 323 per share.
While AstraZeneca's payout ratio might seem low, this can signify that the company is investing more in its future growth.
AstraZeneca's dividend yield is perhaps best considered in relation to those of similar companies.
- Pfizer (PFE.US): 5.64% (5.61% forward annual dividend yield)
- Gilead Sciences (GILD.US): 1.9% (1.93% forward annual dividend yield)
- Johnson-and-Johnson (JNJ.US): 1.93% (1.98% forward annual dividend yield)
- Abbott Laboratories (ABT.US): 2.37% (2.29% forward annual dividend yield)
- IDEXX Laboratories (IDXX.US): (does not pay dividend)
- GSK (GSK.LSE): (3.54% forward annual dividend yield) (does not pay dividend)
-
It's as easy to sell AstraZeneca as it is to buy! Here's how to sell AstraZeneca shares that you already own.
- Open your investment app. If you've got one with desktop access, you can log in online
- Go to your portfolio. This should be in the main menu
- Find your shares. You may be able to search your portfolio
- Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
- Sell your AstraZeneca shares. Your investment platform will let you know when your shares are sold
-
Most dealing providers will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.
-
The easiest way to get hold of some AstraZeneca shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in AstraZeneca shares.
-
No. That's for US stocks.
-
Finder writers are subject matter experts and use primary sources, in-depth research and interviews with other experts to ensure you're getting accurate, up-to-date information. Articles are fact checked in line with our editorial guidelines.
George is a deputy editor at Finder. He has previously written for The Motley Fool UK, Nasdaq, Freetrade, Investing in the Web, MoneyMagpie, Online Mortgage Advisor, Wealth, and Compare Forex Brokers. He's focused on making personal finance and investing engaging for everyone. To do this he draws from previous work and his Level 4 Diploma for Financial Advisers (DipFA), sharing what he’s learnt. When he’s not geeking out about money, you’ll find him playing sports and staying active. See full bio
- Investing
- Personal finance
- Tax
- Pensions
- Mortgages
- Cryptocurrency
More guides on Finder
-
Best care home stocks 2026
Find out the best care home shares along with the pros and cons of investing in this grey-pound-fuelled sector.
-
Mental health stocks: Popular mental health companies to invest in
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
-
Invest in pharmaceutical stocks
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
-
How to buy Eli Lilly and Company shares
Ever wondered how to buy shares in Eli Lilly and Company? We explain how to invest in Eli Lilly in the UK along with platforms for buying stock.
-
How to buy AstraZeneca shares
How to buy shares in Pfizer
-
How to buy GSK shares (with up to £300 free!)
Learn more about GSK’s recent performance and where you can buy GSK shares. We also run through a helpful checklist for anyone looking to invest.
